Approval · Notice of Compliance 27673 · 2022
TACHOSIL: Notice of Compliance 27673
Issued February 25, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 27673
- Date
- February 25, 2022
- Company
- Corza Medical GmbhDusseldorf, Nordrhein-Westfalen, Germany
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Administrative ¿ Transfer of Drug Identification Number (DIN); Labelling updates
Products in this notice
Medicinal ingredients
- ALBUMIN 2.8 MG per SQ CM
- L-ARGININE HCL 2.6 MG per SQ CM
- SODIUM CHLORIDE 1.4 MG per SQ CM
- SODIUM CITRATE 0.4 MG per SQ CM
- THROMBIN (HUMAN) 2 UNIT per SQ CM
- FIBRINOGEN (HUMAN) 5.5 MG per SQ CM
- COLLAGEN 2.1 MG per SQ CM
- ALBUMIN 1,000,000,000 MG per SQ CM
- L-ARGININE HCL 1,000,000,000 MG per SQ CM
- SODIUM CHLORIDE 1,000,000,000 MG per SQ CM
- SODIUM CITRATE 1,000,000,000 MG per SQ CM